Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo.

Laszlo V, Valko Z, Kovacs I, Ozsvar J, Hoda MA, Klikovits T, Lakatos D, Czirok A, Garay T, Stiglbauer A, Helbich TH, Gröger M, Tovari J, Klepetko W, Pirker C, Grusch M, Berger W, Hilberg F, Hegedus B, Dome B.

Clin Cancer Res. 2018 Aug 1;24(15):3729-3740. doi: 10.1158/1078-0432.CCR-17-1507. Epub 2018 May 3.

PMID:
29724868
2.

Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.

Polanec SH, Andrzejewski P, Baltzer PAT, Helbich TH, Stiglbauer A, Georg D, Karanikas G, Susani M, Wadsak W, Margreiter M, Mitterhauser M, Brader P, Pinker K.

PLoS One. 2017 Jul 18;12(7):e0180790. doi: 10.1371/journal.pone.0180790. eCollection 2017.

3.

Individually Stabilized, Superparamagnetic Nanoparticles with Controlled Shell and Size Leading to Exceptional Stealth Properties and High Relaxivities.

Lassenberger A, Scheberl A, Stadlbauer A, Stiglbauer A, Helbich T, Reimhult E.

ACS Appl Mater Interfaces. 2017 Feb 1;9(4):3343-3353. doi: 10.1021/acsami.6b12932. Epub 2017 Jan 20.

4.

[Magnetic resonance tomography-guided interventional procedure for diagnosis of prostate cancer].

Schernthaner M, Helbich TH, Fueger BJ, Margreiter M, Memarsadeghi M, Stiglbauer A, Linhart HG, Doan A, Pinker K, Brader P.

Radiologe. 2011 Nov;51(11):962-8. doi: 10.1007/s00117-011-2180-4. German.

PMID:
22012569
5.

[Diagnose importance of multiparametric magnetic resonance tomography for prostate cancer].

Fueger BJ, Helbich TH, Schernthaner M, Zbýn S, Linhart HG, Stiglbauer A, Doan A, Pinker K, Heinz G, Padhani AR, Brader P.

Radiologe. 2011 Nov;51(11):947-54. doi: 10.1007/s00117-011-2179-x. German.

PMID:
21976041

Supplemental Content

Loading ...
Support Center